Correction to: Scientific Reports https://doi.org/10.1038/s41598-017-07307-4, published online 31 July 2017

The Acknowledgements section in this Article is incomplete.

“We thank Michiyo Tokunaga for technical and secretary support, Alex Zhyvoloup for technical support, and Michi Miura for R program to perform quality check of Index reads. We also thank Heather Niederer for providing materials and Laurence Game and Marian Dore (Genomics Laboratory, Medical Research Council Clinical Sciences Centre, Hammersmith Hospital, London, UK) for sequencing of IS obtained from cells infected with HIV-1 or HTLV-1 in vitro. This study was supported by grants from the JSPS KAKENHI (26461428, 17K09016 and 15H04870 to Y.S., 16KK0206 to H.K., and 15K07166 to K.S.), AIDS International Collaborative Research Grant from the Ministry of Education, Science, Sports, and Culture, and Kumamoto University to Y.S., AMED (15Afk0410013h0001) to Y.K., CREST, JST to K.S., EU HIVINNOV (305137) to A. Fassati, and the Wellcome Trust (WT100291MA) to C.R.M.B. The funder has no role in the study design of the study, collection of data, its interpretation, or the discussion to submit the work for publication.”

should read:

“We thank Michiyo Tokunaga for technical and secretary support, Alex Zhyvoloup for technical support, and Michi Miura for R program to perform quality check of Index reads. We also thank Heather Niederer for providing materials and Laurence Game and Marian Dore (Genomics Laboratory, Medical Research Council Clinical Sciences Centre, Hammersmith Hospital, London, UK) for sequencing of IS obtained from cells infected with HIV-1 or HTLV-1 in vitro. This study was supported by grants from the JSPS KAKENHI (26461428, 17K09016 and 15H04870 to Y.S., 16KK0206 to H.K., and 15K07166 to K.S.), AIDS International Collaborative Research Grant from the Ministry of Education, Science, Sports, and Culture, and Kumamoto University to Y.S., AMED (15Afk0410013h0001) to Y.K., CREST, JST to K.S., EU HIVINNOV (305137) to A. Fassati, and the Wellcome Trust (WT100291MA) to C.R.M.B. The funder has no role in the study design of the study, collection of data, its interpretation, or the discussion to submit the work for publication. We would like to thank the UCLA CFAR Gene and Cellular Therapy Core Facility for providing human CD34+ hematopoietic stem cells (UCLA Center for AIDS Research NIH/NIAID 5P30 AI028697).”